Ignite Creation Date:
2025-12-24 @ 4:51 PM
Ignite Modification Date:
2026-01-20 @ 7:37 AM
Study NCT ID:
NCT01597050
Status:
COMPLETED
Last Update Posted:
2016-07-14
First Post:
2012-05-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
Sponsor:
Rigel Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-08
Start Date Type:
None
Primary Completion Date:
2013-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-09
Completion Date Type:
ACTUAL
First Submit Date:
2012-05-09
First Submit QC Date:
None
Study First Post Date:
2012-05-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-04-28
Results First Submit QC Date:
None
Results First Post Date:
2016-06-08
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-06-15
Last Update Post Date:
2016-07-14
Last Update Post Date Type:
ESTIMATED